Literature DB >> 24021220

Neurobiology of delusions, memory, and insight in Alzheimer disease.

David L Sultzer1, Lorraine P Leskin2, Rebecca J Melrose3, Dylan G Harwood3, Theresa A Narvaez2, Timothy K Ando2, Mark A Mandelkern4.   

Abstract

OBJECTIVE: Delusional thoughts are common among patients with Alzheimer disease (AD) and may be conceptually linked to memory deficits (cannot recall accurate information, which leads to inaccurate beliefs) and poor insight (unable to appreciate the illogic of beliefs). This study's goals were to examine the clinical associations among delusions, memory deficits, and poor insight; explore neurobiologic correlates for these symptoms; and identify shared mechanisms.
METHODS: In a cross-sectional analysis, 88 outpatients with AD (mean Mini-Mental State Exam score: 19.3) were studied. Delusional thoughts were assessed with the Neuropsychiatric Inventory, level of inaccurate insight was assessed with the Neurobehavioral Rating Scale, and memory was assessed with the Mattis Dementia Rating Scale memory subscale. (18)F-fluorodeoxyglucose positron emission tomography was used to measure regional cortical metabolism. Relationships between clinical ratings and regional cortical metabolic activity (voxel-based) were assessed using SPM2.
RESULTS: Patients with delusions had lower Dementia Rating Scale memory subscale scores. Neurobehavioral Rating Scale inaccurate insight scores were no different in those with and without delusions. Cortical metabolic activity was lower in the right lateral frontal cortex, orbitofrontal cortex, and bilateral temporal cortex in patients with delusions. Low cortical metabolic activity in the right lateral, inferior, and medial temporal cortex was associated with poorer memory. This region partially overlapped the region of hypometabolism associated with delusions. In contrast, low cortical metabolic activity in bilateral medial frontal cortex was associated with poor insight.
CONCLUSION: Delusions in AD are associated with dysfunction in specific frontal and temporal cortical regions. Delusions are partially clinically and neurobiologically linked to memory deficits but not to poor insight. Published by Elsevier Inc.

Entities:  

Keywords:  Alzheimer disease; FDG-PET; cerebral metabolism; delusions; insight; memory

Mesh:

Year:  2013        PMID: 24021220      PMCID: PMC4254898          DOI: 10.1016/j.jagp.2013.06.005

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  57 in total

1.  The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Guy M McKhann; David S Knopman; Howard Chertkow; Bradley T Hyman; Clifford R Jack; Claudia H Kawas; William E Klunk; Walter J Koroshetz; Jennifer J Manly; Richard Mayeux; Richard C Mohs; John C Morris; Martin N Rossor; Philip Scheltens; Maria C Carrillo; Bill Thies; Sandra Weintraub; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

Review 2.  Neuropathology of Alzheimer's disease: what is new since A. Alzheimer?

Authors:  E Braak; K Griffing; K Arai; J Bohl; H Bratzke; H Braak
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1999       Impact factor: 5.270

3.  Relationships between behavioral syndromes and cognitive domains in Alzheimer disease: the impact of mood and psychosis.

Authors:  Jeremy Koppel; Terry E Goldberg; Marc L Gordon; Edward Huey; Peter Davies; Linda Keehlisen; Sara Huet; Erica Christen; Blaine S Greenwald
Journal:  Am J Geriatr Psychiatry       Date:  2012-11       Impact factor: 4.105

Review 4.  Neuroimaging of delusions in Alzheimer's disease.

Authors:  Zahinoor Ismail; Minh-Quan Nguyen; Corinne E Fischer; Tom A Schweizer; Benoit H Mulsant
Journal:  Psychiatry Res       Date:  2012-06-14       Impact factor: 3.222

5.  β-Amyloid 42/40 ratio and kalirin expression in Alzheimer disease with psychosis.

Authors:  Patrick S Murray; Caitlin M Kirkwood; Megan C Gray; Milos D Ikonomovic; William R Paljug; Eric E Abrahamson; Ruth A Henteleff; Ronald L Hamilton; Julia K Kofler; William E Klunk; Oscar L Lopez; Peter Penzes; Robert A Sweet
Journal:  Neurobiol Aging       Date:  2012-03-17       Impact factor: 4.673

6.  Delusions in Alzheimer's disease: spet evidence of right hemispheric dysfunction.

Authors:  R T Staff; M F Shanks; L Macintosh; S J Pestell; H G Gemmell; A Venneri
Journal:  Cortex       Date:  1999-09       Impact factor: 4.027

7.  Cerebral metabolism, cognition, and functional abilities in Alzheimer disease.

Authors:  Rebecca J Melrose; Mark L Ettenhofer; Dylan Harwood; Natalie Achamallah; Olivia Campa; Mark Mandelkern; David L Sultzer
Journal:  J Geriatr Psychiatry Neurol       Date:  2011-09       Impact factor: 2.680

8.  Impaired insight in Alzheimer disease: association with cognitive deficits, psychiatric symptoms, and behavioral disturbances.

Authors:  D G Harwood; D L Sultzer; M V Wheatley
Journal:  Neuropsychiatry Neuropsychol Behav Neurol       Date:  2000-04

9.  Brain SPECT findings of anosognosia in Alzheimer's disease.

Authors:  Fereshteh Sedaghat; Eleni Dedousi; Ioannis Baloyannis; Thomas Tegos; Vasiliki Costa; Athanasios S Dimitriadis; Stavros J Baloyannis
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

10.  Neuropsychiatric symptoms and syndromes in a large cohort of newly diagnosed, untreated patients with Alzheimer disease.

Authors:  Gianfranco Spalletta; Massimo Musicco; Alesandro Padovani; Luca Rozzini; Roberta Perri; Lucia Fadda; Vincenzo Canonico; Alberto Trequattrini; Carla Pettenati; Carlo Caltagirone; Katie Palmer
Journal:  Am J Geriatr Psychiatry       Date:  2010-11       Impact factor: 4.105

View more
  15 in total

1.  Gray Matter Changes Associated With the Development of Delusions in Alzheimer Disease.

Authors:  Winnie Qian; Tom A Schweizer; Nathan W Churchill; Colleen Millikin; Zahinoor Ismail; Eric E Smith; Lisa M Lix; David G Munoz; Joseph J Barfett; Tarek K Rajji; Corinne E Fischer
Journal:  Am J Geriatr Psychiatry       Date:  2018-10-02       Impact factor: 4.105

Review 2.  The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable.

Authors:  David S Knopman; Samantha Budd Haeberlein; Maria C Carrillo; James A Hendrix; Geoff Kerchner; Richard Margolin; Paul Maruff; David S Miller; Gary Tong; Maria B Tome; Melissa E Murray; Peter T Nelson; Mary Sano; Niklas Mattsson; David L Sultzer; Thomas J Montine; Clifford R Jack; Hartmuth Kolb; Ronald C Petersen; Prashanthi Vemuri; Megan Zoschg Canniere; Julie A Schneider; Susan M Resnick; Gary Romano; Argonde Corien van Harten; David A Wolk; Lisa J Bain; Eric Siemers
Journal:  Alzheimers Dement       Date:  2018-04       Impact factor: 21.566

Review 3.  Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease.

Authors:  Kentaro Hirao; Gregory M Pontone; Gwenn S Smith
Journal:  Neurosci Biobehav Rev       Date:  2014-11-20       Impact factor: 8.989

Review 4.  Dantrolene, a treatment for Alzheimer disease?

Authors:  Li Liang; Huafeng Wei
Journal:  Alzheimer Dis Assoc Disord       Date:  2015 Jan-Mar       Impact factor: 2.703

5.  Accelerated atrophy in dopaminergic targets and medial temporo-parietal regions precedes the onset of delusions in patients with Alzheimer's disease.

Authors:  Riccardo Manca; Jose Manuel Valera-Bermejo; Annalena Venneri
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-05-13       Impact factor: 5.270

Review 6.  Psychosis in Alzheimer disease - mechanisms, genetics and therapeutic opportunities.

Authors:  Zahinoor Ismail; Byron Creese; Dag Aarsland; Helen C Kales; Constantine G Lyketsos; Robert A Sweet; Clive Ballard
Journal:  Nat Rev Neurol       Date:  2022-01-04       Impact factor: 44.711

Review 7.  Principles and management of neuropsychiatric symptoms in Alzheimer's dementia.

Authors:  Milap A Nowrangi; Constantine G Lyketsos; Paul B Rosenberg
Journal:  Alzheimers Res Ther       Date:  2015-01-29       Impact factor: 6.982

Review 8.  Behavioral and psychological symptoms in Alzheimer's disease.

Authors:  Xiao-Ling Li; Nan Hu; Meng-Shan Tan; Jin-Tai Yu; Lan Tan
Journal:  Biomed Res Int       Date:  2014-07-15       Impact factor: 3.411

Review 9.  Role of Hybrid Brain Imaging in Neuropsychiatric Disorders.

Authors:  Amer M Burhan; Nicole M Marlatt; Lena Palaniyappan; Udunna C Anazodo; Frank S Prato
Journal:  Diagnostics (Basel)       Date:  2015-12-04

Review 10.  Brain mechanisms underlying neuropsychiatric symptoms in Alzheimer's disease: a systematic review of symptom-general and -specific lesion patterns.

Authors:  Yaojing Chen; Mingxi Dang; Zhanjun Zhang
Journal:  Mol Neurodegener       Date:  2021-06-07       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.